» Articles » PMID: 15767418

Vesicular Stomatitis Viruses Expressing Wild-type or Mutant M Proteins Activate Apoptosis Through Distinct Pathways

Overview
Journal J Virol
Date 2005 Mar 16
PMID 15767418
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Vesicular stomatitis virus (VSV) induces apoptosis by at least two mechanisms. The viral matrix (M) protein induces apoptosis via the mitochondrial pathway due to the inhibition of host gene expression. However, in some cell types, the inhibition of host gene expression by VSV expressing wild-type (wt) M protein delays VSV-induced apoptosis, indicating that another mechanism is involved. In support of this, the recombinant M51R-M (rM51R-M) virus, expressing a mutant M protein that is defective in its ability to inhibit host gene expression, induces apoptosis much more rapidly in L929 cells than do viruses expressing wt M protein. Here, we determine the caspase pathways by which the rM51R-M virus induces apoptosis. An analysis of caspase activity, using fluorometric caspase assays and Western blots, indicated that each of the main initiator caspases, caspase-8, caspase-9, and caspase-12, were activated during infection with the rM51R-M virus. The overexpression of Bcl-2, an inhibitor of the mitochondrial pathway, or MAGE-3, an inhibitor of caspase-12 activation, did not delay apoptosis induction in rM51R-M virus-infected L929 cells. However, an inhibitor of caspase-8 activity significantly delayed apoptosis induction. Furthermore, the inhibition of caspase-8 activity prevented the activation of caspase-9, suggesting that caspase-9 is activated by cross talk with caspase-8. These data indicate that VSV expressing the mutant M protein induces apoptosis via the death receptor apoptotic pathway, a mechanism distinct from that induced by VSV expressing the wt M protein.

Citing Articles

Vesicular Stomatitis Virus: Insights into Pathogenesis, Immune Evasion, and Technological Innovations in Oncolytic and Vaccine Development.

Ahmed M, Okesanya O, Ukoaka B, Ibrahim A, Lucero-Prisno 3rd D Viruses. 2025; 16(12.

PMID: 39772239 PMC: 11680291. DOI: 10.3390/v16121933.


Oncolytic vesicular stomatitis virus alone or in combination with JAK inhibitors is effective against ovarian cancer.

Geoffroy K, Mullins-Dansereau V, Leclerc-Desaulniers K, Viens M, Bourgeois-Daigneault M Mol Ther Oncol. 2024; 32(3):200826.

PMID: 39006945 PMC: 11246050. DOI: 10.1016/j.omton.2024.200826.


Matrix Protein of Vesicular Stomatitis Virus Targets the Mitochondria, Reprograms Glucose Metabolism, and Sensitizes to 2-Deoxyglucose in Glioblastoma.

Zhou Y, Li Y, Chenm J, Mei K, Kang M, Chen P Hum Gene Ther. 2024; 35(19-20):838-854.

PMID: 39001830 PMC: 11511779. DOI: 10.1089/hum.2024.002.


Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, sensitizes cancer cells to VSVΔ51 oncolytic virotherapy.

Wong B, Bergeron A, Maznyi G, Ng K, Jirovec A, Birdi H Mol Ther. 2023; 31(11):3176-3192.

PMID: 37766429 PMC: 10638453. DOI: 10.1016/j.ymthe.2023.09.017.


Exploring the Molecular Basis of Vesicular Stomatitis Virus Pathogenesis in Swine: Insights from Expression Profiling of Primary Macrophages Infected with M51R Mutant Virus.

Velazquez-Salinas L, Medina G, Valdez F, Zarate S, Collinson S, Zhu J Pathogens. 2023; 12(7).

PMID: 37513744 PMC: 10384765. DOI: 10.3390/pathogens12070896.


References
1.
Yuan H, Puckett S, Lyles D . Inhibition of host transcription by vesicular stomatitis virus involves a novel mechanism that is independent of phosphorylation of TATA-binding protein (TBP) or association of TBP with TBP-associated factor subunits. J Virol. 2001; 75(9):4453-8. PMC: 114196. DOI: 10.1128/JVI.75.9.4453-4458.2001. View

2.
Wallach D, Boldin M, Varfolomeev E, Beyaert R, Vandenabeele P, Fiers W . Cell death induction by receptors of the TNF family: towards a molecular understanding. FEBS Lett. 1997; 410(1):96-106. DOI: 10.1016/s0014-5793(97)00553-x. View

3.
Kopecky S, Willingham M, Lyles D . Matrix protein and another viral component contribute to induction of apoptosis in cells infected with vesicular stomatitis virus. J Virol. 2001; 75(24):12169-81. PMC: 116113. DOI: 10.1128/JVI.75.24.12169-12181.2001. View

4.
von Kobbe C , van Deursen JM , Rodrigues J, Sitterlin D, Bachi A, Wu X . Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin Nup98. Mol Cell. 2000; 6(5):1243-52. DOI: 10.1016/s1097-2765(00)00120-9. View

5.
Morishima N, Nakanishi K, Takenouchi H, Shibata T, Yasuhiko Y . An endoplasmic reticulum stress-specific caspase cascade in apoptosis. Cytochrome c-independent activation of caspase-9 by caspase-12. J Biol Chem. 2002; 277(37):34287-94. DOI: 10.1074/jbc.M204973200. View